The Kushida Study highlights why Tropocells stands out as a leading PRP kit:
✅ High Platelet Concentration
Achieve a 3x boost in platelet levels, aligning with clinical standards for regenerative excellence.
✅ Growth Factor Efficacy
Packed with PDGF-AB, TGF-β1, and VEGF—essential for healing, angiogenesis, and tissue regeneration.
✅ Low RBC Count
Minimal red blood cell contamination reduces inflammation, enhancing outcomes.
✅ Convenience & Cost-Effectiveness
Closed-system technology offers consistency, safety, and affordability in one package.
✅ Healing Potential
Perfect for a variety of procedures with its high growth factor levels and low RBC count.
Choose Tropocells for clinical precision and transformative results in regenerative and cosmetic applications.
Tropocells FAQs
Based on findings from the Kushida Study
Q1: What makes Tropocells unique compared to other PRP kits?
A: Tropocells produces PRP with high platelet concentrations, competitive levels of growth factors (PDGF-AB, TGF-β1, VEGF), and minimal red blood cell (RBC) contamination, making it ideal for regenerative medicine and cosmetic applications.
Q2: How does Tropocells ensure high platelet concentration?
A: Using advanced closed-system gel separation technology, Tropocells achieves a threefold increase in platelet concentration, aligning with clinical recommendations for effective PRP preparation.
Q3: Why are growth factors in Tropocells PRP important?
A: Key growth factors like PDGF-AB, TGF-β1, and VEGF promote healing, angiogenesis, tissue regeneration, and cell proliferation, enhancing therapeutic outcomes.
Q4: How does Tropocells minimize red blood cell contamination?
A: The specialized separation process reduces RBC content significantly, helping to lower inflammation and improve patient comfort, particularly in cosmetic procedures.
Q5: Is Tropocells cost-effective?
A: Tropocells offers a balanced combination of affordability and performance. Its closed-system design ensures consistency, safety, and ease of use.
Q6: What applications benefit from Tropocells?
A: Tropocells is highly effective for regenerative applications, such as wound healing and tissue repair, as well as cosmetic procedures requiring tissue rejuvenation.
Q7: Is there scientific evidence supporting Tropocells’ effectiveness?
A: The Kushida study compared Tropocells to six other commercial PRP kits and found it to be superior in platelet concentration, growth factor levels, and low RBC contamination.
The Kushida study highlights key advantages of Tropocells in comparison to other PRP kits:
- High Platelet Concentration: Tropocells produces PRP with elevated platelet levels, which is essential for regenerative applications. It achieves a threefold increase in platelet concentration, aligning with clinical recommendations for effective PRP preparation.
- Growth Factor Efficacy: Tropocells demonstrates competitive concentrations of Platelet-Derived Growth Factor-AB (PDGF-AB), Transforming Growth Factor-Beta 1 (TGF-β1), and Vascular Endothelial Growth Factor (VEGF). These growth factors are critical for wound healing, angiogenesis, and tissue regeneration.
- Low Red Blood Cell (RBC) Count: Unlike some kits with high RBC contamination, Tropocells minimizes RBC content, making it suitable for applications where reduced inflammatory response is desired.
- Convenience and Cost-Effectiveness: The closed-system gel separation technology of Tropocells ensures ease of use, consistency, and reduced risk of contamination, offering a balance between performance and affordability.
- Application Potential: With low RBC counts and high platelet and growth factor levels, Tropocells is particularly promising for procedures requiring tissue repair and rejuvenation.
These attributes position Tropocells as a superior choice for PRP preparation in clinical fields. If you would like more information about the Kushida study, please contact us.
Findings derived from the Kushida Study which compared Tropocells with six other commercial PRP kits.
Source: Kushida, S., Kakudo, N., Morimoto, N., Hara, T., Ogawa, T., Mitsui, T., & Kusumoto, K. (2014). Platelet and growth factor concentrations in activated platelet-rich plasma: A comparison of seven commercial separation systems. Journal of Artificial Organs. DOI: 10.1007/s10047-014-0761-5.
This study evaluates the platelet, white blood cell, red blood cell, and growth factor concentrations in PRP prepared using seven different commercial PRP kits, including Tropocells.
Questions?
- Call us at: 833-713-3414
- Email us at: sales@transcendbiologics.com
Recent Comments